Updated Jul 16, 2026
Tennant Phil has filed 3 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $21K. Lifetime open-market sales: $132K.
Phil Tennant is the Chief Commercial Officer at Precigen, Inc., a biotechnology company focused on synthetic biology solutions. He has been involved in the company's commercial strategies and operations.
| Role | Chief Commercial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 30.3K | $4.36 | $132K |
| 2026-05-28 | PGEN | PRECIGEN, INC. | M — Option exercise | 62.5K | — | |
| 2026-03-20 | PGEN | PRECIGEN, INC. | M — Option exercise | 42.1K | — | |
| 2025-09-29 | PGEN | PRECIGEN, INC. | P — Open-market purchase | 6.0K | $3.58 | $21K |
Phil Tennant is the Chief Commercial Officer at Precigen, Inc., a biotechnology company focused on synthetic biology solutions. He has been involved in the company's commercial strategies and operations.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($21K) and 1 open-market sales ($132K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tennant Phil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.